Gastrointestinal/liver-targeted TLR7 agonist for treatment of colorectal and liver cancers

被引：1
|
作者：
Miller, Andrew T. [1 ]
Rodrigo, Evelyn [1 ]
Corpuz, Manny [1 ]
Plouffe, David [1 ]
Wu, Tom Y-H [1 ]
机构：
[1] Apros Therapeut, San Diego, CA USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-684
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
684
引用
收藏
页数：1
相关论文
共 50 条
  • [1] ETHANOL EXPOSURE INCREASES HEPATIC TLR7 EXPRESSION AND SENSITIZES THE LIVER TO INFLAMMATORY RESPONSE CAUSED BY THE TLR7 AGONIST IMIQUIMOD
    Massey, V. L.
    Qin, L.
    Bataller, R.
    Crews, F. T.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2017, 41 : 124A - 124A
  • [2] Deoxyguanosine is a TLR7 agonist
    Davenne, Tamara
    Bridgeman, Anne
    Rigby, Rachel E.
    Rehwinkel, Jan
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2020, 50 (01) : 56 - 62
  • [3] Phase 1 study of RO7119929 (TLR7 agonist prodrug) in patients (pts) with advanced primary or metastatic liver cancers
    Yoo, Changhoon
    Verdaguer, Helena
    Lin, Chia-Chi
    Qvortrup, Camilla
    Yau, Thomas
    Oh, Do-Youn
    Lichtenegger, Felix
    Franjkovic, Izolda
    Kratochwil, Nicole
    Bessa, Juliana
    Rossmann, Eva
    Hall, Elia
    Dai, Congqi
    Krieter, Oliver
    Te-Ying, Audrey Yeo
    Cannarile, Michael
    Schiff, Christina
    Sangro, Bruno
    CANCER RESEARCH, 2023, 83 (08)
  • [4] COMBINATION TREATMENT OF LIVER-TARGETED HBV LOCKED NUCLEIC ACID ANTISENSE OLIGONUCLEOTIDE AND TLR7 AGONIST RO7020531 LEADS TO PROLONGED OFF-TREATMENT ANTIVIRAL EFFECT IN THE AAV-HBV MOUSE MODEL.
    Blaising, Julie
    Yu, Youjun
    Zhou, Xue
    Pedersen, Lykke
    Wildum, Steffen
    Ottosen, Soren
    Wat, Cynthia
    Gao, Lu
    Mueller, Henrik
    HEPATOLOGY, 2019, 70 : 428A - 429A
  • [5] Screening of liver-targeted drugs
    Midorikawa, Yutaka
    Sugiyama, Yasuyuki
    Aburatani, Hiroyuki
    EXPERT OPINION ON DRUG DISCOVERY, 2008, 3 (06) : 643 - 654
  • [6] APR003, AN ORAL LIVER- AND GI-TARGETED TLR7 AGONIST, ELICITS A ROBUST TYPE I INTERFERON RESPONSE IN ADVANCED COLORECTAL CANCER PATIENTS
    Miller, Andrew
    Le, Trinh
    Holland, Jaymes
    Weitzman, Ron
    Wu, Tom
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1210 - A1210
  • [7] Rejuvenation of exhausted CAR-T cells with a targeted TLR7 agonist
    Low, Philip S.
    Luo, Qian
    Napoleon, John Victor
    Zhang, Boning
    CANCER RESEARCH, 2020, 80 (16)
  • [8] DISCOVERY OF LIVER-TARGETED ORAL PDL1 SMALL MOLECULE INHIBITORS FOR THE TREATMENT OF CHRONIC HEPATITIS B AND LIVER CANCERS
    Wu, Tongfei
    Stevens, Sarah K.
    Liu, Cheng
    Roose, Heleen
    Rekstyte-Matiene, Kristina
    Behaeghel, Elke
    Mukherjee, Sucheta
    Chang, Sandra
    Jaisinghani, Ruchika
    Stoycheva, Antitsa
    Zhang, Qingling
    Gupta, Kusum
    Jekle, Andreas
    Deval, Jerome
    Symons, Julian A.
    Blatt, Lawrence M.
    Beigelman, Leonid N.
    Raboisson, Pierre
    Gonzalvez, Francois
    HEPATOLOGY, 2022, 76 : S25 - S26
  • [9] Reduction of Hepatic Steatosis in Rats and Mice After Treatment with a Liver-Targeted Thyroid Hormone Receptor Agonist
    Cable, Edward E.
    Finn, Patricia D.
    Stebbins, Jeffrey W.
    Hou, Jinzhao
    Ito, Bruce R.
    van Poelje, Paul D.
    Linemeyer, David L.
    Erion, Mark D.
    HEPATOLOGY, 2009, 49 (02) : 407 - 417
  • [10] Prevalence of TLR7 polymorphisms in patients with chronic liver disease
    Schott, Eckart
    Witt, Heiko
    Vierich, Sandra
    Weich, Viola
    Halangk, Juliane
    Bergk, Alexandra
    Sarrazin, Christoph
    Wiedenmann, Bertram
    Thomas, Berg
    HEPATOLOGY, 2006, 44 (04) : 311A - 311A
12345